<abstract xmlns="http://www.w3.org/1999/xhtml">

Acute pulmonary embolism is a cardiovascular emergency with a significant morbidity and mortality. In the last decade, attempts have been made to find prognostic markers for pulmonary embolism. We conducted a systematic review of the literature for studies that assess the relationship between the neutrophil-to-lymphocyte ratio (NLR) and disease progression in patients with pulmonary embolism. We included a total of seven studies published between 2016 and 2021, reporting on a total of 4,272 patients. The mean NLR observed in these studies was 5.93, with values ranging from 5.12 to 7.3. Elevated NLR was significantly associated with an increased rate of mortality in all studies. Furthermore, the collected data revealed a 2-to-15 times higher mortality rate in the group with NLR values higher than the mean. Due to its accessibility and the simplicity with which it can be calculated, as well as the outcomes revealed in this review, we strongly emphasize that NLR should be used more in medical practice.
</abstract>

“George Emil Palade” University of Medicine, Pharmacy, Science and Technology

Faculty of Pharmacy, “George Emil Palade” University of Medicine, Pharmacy, Science and Technology

The Neutrophil-to-Lymphocyte Ratio’s Predictive Utility in Acute Pulmonary Embolism: Systematic Review

<abstract xmlns="http://www.w3.org/1999/xhtml">

In acute coronary syndromes, timely revascularization of the obstructed artery is crucial. In young patients, acute myocardial infarction can have a very severe evolution and is frequently associated with cardiogenic shock. We present the case of a 36-year-old male patient, smoker with no other apparent risk factors for coronary artery disease, who suffered a cardiac arrest while playing tennis. Emergency coronary angiography revealed acute occlusion of the left anterior descendent artery, which was promptly revascularized. The patient had a good clinical evolution and was discharged after six days. The case underlines the importance of a well-functioning emergency system and STEMI network, able to provide life-saving therapy in a timely manner.
</abstract>

Acute Thrombosis of the Left Main on the Tennis Court in a Young Patient – a Case Report

<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Introduction:</bold> Atherosclerosis represents the main cause of arterial stenosis, mostly affecting the arteries of the lower extremities. Atherosclerotic arterial disease presents multiple localizations, including the carotid, subclavian, coronary, and kidney arteries. The severity of the stenosis does not always correlate with the symptomatology.
<bold>Case report:</bold> We present the case of a patient with multisite atherosclerotic disease. A 70-year-old smoker male patient, with a history of myocardial infarction and renal artery stenosis, presented in the emergency department complaining of vertigo, chest pain, and intermittent claudication. The diagnostic and treatment algorithm represented a challenge. Imaging assessment showed atherosclerotic lesions in a new vascular territory, which involved the left subclavian artery with a stenosis of 70%.
<bold>Conclusions:</bold> Subclavian artery stenosis can be a hidden form of atherosclerotic disease, often undiagnosed, which needs urgent interventional treatment and can be easily unmasked using simple tools such as measuring the blood pressure on both arms. Patients with athero-sclerotic lesions must undergo comprehensive screening for multisite atherosclerotic disease.
</abstract>

“George Emil Palade” Universisity of Medicine, Pharmacy, Science and Tehnology, Târgu Mureș

Diagnostic and Treatment Algorithm in a Plurivascular Patient – Case Report

<abstract xmlns="http://www.w3.org/1999/xhtml">

Cardiovascular disorders have been described as relevant risk factor for severe COVID infection. Stent thrombosis is a life-threatening complication that may occur subacutely. We present an interesting case of a middle-aged woman who developed acute stent thrombosis while interrupting dual antiplatelet therapy (DAPT) ticagrelor, during an episode of coronavirus disease (COVID-19). In our case, the patient’s not-compliance to DAPT, associated with COVID-19 infection and a hyperinflammatory and hypercoagulable state associated with it played a major role in the development of stent thrombosis. The hypercoagulable and hyperinflammatory state associated with COVID-19 has important implications for cardiac patients, especially those undergoing complex coronary intervention, predisposing them to an increased risk of post-PCI complications.
</abstract>

Double Trouble: Interrupting DAPT and COVID-19

AHEAD OF PRINT

Volume 10 (2024): Issue 1 (March 2024)

Volume 9 (2023): Issue 4 (December 2023)

Volume 9 (2023): Issue 3 (September 2023)

Volume 9 (2023): Issue 2 (June 2023)

Volume 9 (2023): Issue 1 (March 2023)

Volume 8 (2022): Issue 4 (December 2022)

Volume 8 (2022): Issue 3 (September 2022)

Volume 8 (2022): Issue 2 (June 2022)

Volume 8 (2022): Issue 1 (March 2022)

Volume 7 (2021): Issue 4 (January 2021)

Volume 7 (2021): Issue 3 (September 2021)

Volume 7 (2021): Issue 2 (June 2021)

Volume 7 (2021): Issue 1 (March 2021)

Volume 6 (2020): Issue 4 (December 2020)

Volume 6 (2020): Issue 3 (September 2020)

Volume 6 (2020): Issue 2 (June 2020)

Volume 6 (2020): Issue 1 (March 2020)

Volume 5 (2019): Issue 4 (December 2019)

Volume 5 (2019): Issue 3 (September 2019)

Volume 5 (2019): Issue 2 (June 2019)

Volume 5 (2019): Issue 1 (March 2019)

Volume 4 (2018): Issue 4 (December 2018)

Volume 4 (2018): Issue 3 (September 2018)

Volume 4 (2018): Issue 2 (June 2018)

Volume 4 (2018): Issue 1 (March 2018)

Volume 3 (2017): Issue 4 (December 2017)

Volume 3 (2017): Issue 3 (September 2017)

Volume 3 (2017): Issue 2 (June 2017)

Volume 3 (2017): Issue 1 (March 2017)

Volume 2 (2016): Issue 4 (December 2016)

Volume 2 (2016): Issue 3 (September 2016)

Volume 2 (2016): Issue 2 (June 2016)

Volume 2 (2016): Issue 1 (March 2016)

Volume 1 (2015): Issue 2 (December 2015)

Volume 1 (2015): Issue 1 (July 2015)

Journal of Cardiovascular Emergencies

 The Journal of Cardiovascular Emergencies aims to publish top quality papers related to acute conditions in any cardiovascular pathology. The journal will mainly focus on recent advances in the field of diagnosis and treatment of the most common causes of cardiovascular emergencies, including acute coronary syndromes, acute heart failure, acute aortic diseases, pulmonary embolism, peripheral arterial diseases or cardiac arrhythmia. Interdisciplinary approaches will be extremely welcomed, presenting new advances in the approach of different other pathologies (i.e. stroke) from the cardiovascular perspective.  The Journal of Cardiovascular Emergencies will publish high-quality basic and clinical research related to these topics, in a common approach that will integrate the clinical studies with the pre-clinical work dedicated to discovery of new mechanisms involved in the development and progression of acute cardiovascular conditions.  Especially in the case of acute coronary syndromes, the journal will try to provide the entire cardiology community with the perspective of the regional cardiology networks in Central and Eastern European countries, reflecting the regional model of care in cardiovascular acute conditions.  The journal will primarily focus on publishing original research papers, but also other types of materials (such as review articles, case reports, state of the art papers, comments to editor, etc) will be extremely welcomed.  Rejection Rate   30%   Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 